Page 3 - Opgen News Today

Allspring Global Investments Holdings LLC boosted its holdings in shares of Precigen, Inc. (NASDAQ:PGEN – Free Report) by 1,092.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 52,272 shares of the biotechnology company’s stock after purchasing an additional 47,888 shares […]

OpGen, Inc. (NASDAQ:OPGN – Get Free Report) was the recipient of a significant decrease in short interest in the month of October. As of October 31st, there was short interest totalling 379,900 shares, a decrease of 60.1% from the October 15th total of 952,800 shares. Based on an average daily trading volume, of 4,600,000 shares, […]

StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report report published on Thursday. The firm issued a sell rating on the medical research company’s stock. Separately, HC Wainwright lowered OpGen from a buy rating to a neutral rating in a research note on Monday, August 14th. Check Out Our […]

Precigen, Inc. (NASDAQ:PGEN – Get Free Report)’s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.29 and traded as low as $1.10. Precigen shares last traded at $1.16, with a volume of 889,320 shares changing hands. Wall Street Analysts Forecast Growth Several […]

StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note released on Wednesday. The brokerage issued a hold rating on the medical research company’s stock. Separately, HC Wainwright lowered OpGen from a buy rating to a neutral rating in a research report on Monday, August 14th. View Our Latest Research […]

By Colin Kellaher Shares of OpGen surged more than sixfold in premarket trading Thursday after the precision-medicine company said it was in talks on a...

Equities researchers at StockNews.com initiated coverage on shares of Precigen (NASDAQ:PGEN – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a “buy” rating and set a $6.00 target price on shares of Precigen in a research […]

StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a hold rating on the medical research company’s stock. Separately, HC Wainwright downgraded shares of OpGen from a buy rating to a neutral rating in a research report on Monday, August 14th. […]

OpGen (NASDAQ:OPGN – Get Free Report) and Aclarion (NASDAQ:ACON – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, profitability, analyst recommendations and dividends. Analyst Ratings This is a summary of recent ratings […]

StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note published on Sunday. The firm issued a hold rating on the medical research company’s stock. Separately, HC Wainwright cut OpGen from a buy rating to a neutral rating in a research report on Monday, August 14th. Read Our Latest Analysis […]